Arvind Subramanian is an Indian economist and the current Chief Economic Adviser to the Government of India, having taken charge of the position on 16 October 2014 succeeding Raghuram Rajan. The post of CEA was lying vacant for over a year since Raghuram Rajan left the finance ministry to join the RBI as governor in September 2013.
He served as the Dennis Weatherstone Senior Fellow at the Peterson Institute for International Economics and a Senior Fellow at the Center for Global Development, both located in Washington DC. Formerly an economist at the International Monetary Fund, he is a widely cited expert on the economics of India, China, and the changing balance of global economic power. Arvind Subramanian is the author of two books, India's Turn: Understanding the Economic Transformation published in 2008, Eclipse: Living in the Shadow of China's Economic Dominance published in September 2011, and co-author of Who Needs to Open the Capital Account? which was published in 2012.
In 2011, Foreign Policy magazine named him one of the world's top 100 global thinkers.
Education:
Subramanian is a graduate of St Stephen's College, Delhi, and did his MBA from the Indian Institute of Management, Ahmedabad. Further, he obtained his M Phil and D Phil from the University of Oxford, UK. He attended the DAV Boy's Senior Secondary School, Chennai, for his high school education.
Positions held:
Subramanian was the Assistant Director in the Research Department of the International Monetary Fund. He is a development economist who worked closely with Reserve Bank of India Governor Raghuram Rajan when both were at the International Monetary Fund. He served at the GATT during the Uruguay Round of trade negotiations. He has taught at Harvard University's Kennedy School of Government from 1999 to 2000. He has also taught at Johns Hopkins' School for Advanced International Studies from 2008 to 2010. Arvind Subramanian's elder brother is V S Krishnan who is an Indian Revenue Service Officer and is presently the Member of the Central Board of Excise and Customs and is a key player in piloting the Goods and Service Tax Bill.
In October 2014, he was appointed as Chief Economic Advisor to Indian government. The post of CEA had been lying vacant since Raghuram Rajan left the Finance Ministry to join the Reserve Bank as Governor in September 2013.
Controversies:
As a Senior Fellow, Peterson Institute for International Economics and Center for Global Development, in March 2013, Arvind Subramanian appeared before United States House Committee on Ways and Means hearing on “US-India trade relations.”. During his testimony, Arvind Subramanian said "by discriminating against Indian companies and exporters, (US initiatives) will exert natural pressure on India to open up".
Ashok Vemuri (born April 22, 1968) is the current Group Management Board Member at Capgemini,and the former President and CEO of IGATE Corporation and was also a member of its board. On April 27 2015 French IT services group Capgemini unveiled a deal to acquire IGATE in a $4bn deal.Vemuri was previously a member of the board at Infosys Limited, Head of Americas and Global Head of Manufacturing and Engineering Services.Vemuri will become CEO of Xerox Business Services LLC on July 1 2016.
Early life and education:'
After graduating with a degree in physics from St. Stephen's College, Delhi, Vemuri completed his master’s degree in business management from the Indian Institute of Management, Ahmedabad, in 1992 before joining Deutsche Bank.
Career:
Prior to joining Infosys, he worked in investment banking at Deutsche Bank AG.He later moved to Bank of America, in 1995 before joining Infosys in 1999, where he worked for Narayana Murthy, the co-founder and then-CEO of Infosys, where he was head of Infosys Americas and global head of manufacturing and engineering services.
In his role as a board member and head of Infosys’s Americas business, Vemuri was chairman of the company’s China operations and helped to set up its now largest business division, banking and financial services, which at the time was the company's largest region in terms of clients and revenues.
Awards and recognition:
Vemuri received the "CEO of the year" award in 2014 from IAIR in Hong Kong in March, 2015.
Outstanding Entrepreneurship Award - 2015 by Enterprise Asia, a non-governmental organization that promotes entrepreneurship in the Asia Pacific region. In 2014,
Vemuri was elected to the Board of IT Governors at the World Economic Forum (WEF), Davos. In 2013, he was included in the "50 Outstanding Asian Americans in Business" by the Asian American Business Center. In 2009,
He was elected to the Forum of Young Global Leaders (YGL) by the WEF.
In 2008, he was selected by leading Indian magazine, Business Today, as one of India's 25 Hottest Young Executives.He has appeared on CNBC,and NDTV.
He is on the Board of Visitors of the Fuqua School of Business at Duke University.
Full Name : Aubrey Kerr McClendon
Born : 14th - Jul - 1959
Zodiac Sign : Cancer
Height : 186 CMS (6 Feet 1 Inches)
Birth Place : Oklahoma City, Oklahoma
Country : USA
Education : Duke University Durham
Occupation : CEO
Industry : Business
Net worth : $1.2 billion
Aubrey McClendon is a man surrounded by controversy, even in his sudden mysterious death. Aubrey is a natural oil and gas industry tycoon who cofounded Chesapeake Energy Corporation. He died in a car crush that has raised a lot of eyebrows. There is speculation that Aubrey might have taken his own life. He was in his car alone and allegedly hit straight into a brick wall. Aubrey had a chance to get back on the highway, but chose not to. McClendon died on Wednesday in Oklahoma after being indicted by a grand jury on Tuesday. He was indicted for rigging bids to buy leases of oil and natural gas.
According to the Department of Justice, Aubrey began a scheme with two energy corporations between 2007 and 2012. The agreement was for the companies to avoid bidding against each other. They were to decide a winner prior the biddings in Oklahoma and allocate each other leases accordingly. Aubrey however denied the allegations as a mere scheme to tarnish his reputation. He said that he had committed his life to the oil and gas sector, to provide employment opportunities and plenty of safe gas to the country. McClendon risked 10 years in jail if evidence pointed towards him for violating the Sherman Act.
McClendon cofounded Chesapeake Energy at 29 years old in 1989. The company drilled its first two wells in May of that year in Garvin county Oklahoma. He adopted the use of horizontal drilling and hydraulic fracturing techniques, which skyrocketed Chesapeake to tremendous growth. He was later branded a visionary leader because of these new and unconventional well drilling techniques. Forbes recognized McClendon as America’ productive C.E.O because of his tremendous works at Chesapeake.
McClendon is an advocate of natural gas because of its environment friendly abilities as opposed to alternative oil and coal fuels. In support of the natural oil industry, Aubrey cofounded a lobbying group for natural gas. He further financed a campaign to engage natural gas activists on a Texas utility plan to build 11 coal plants
McClendon left Chesapeake in 2013 following a controversy in his tenure. During this time, oil prices greatly reduced causing the company millions. Investors were concerned about the pricing, which cost Aubrey his annual bonus. He left the company that same year.
Despite his exit, his legacy still stood as a top shale gas producer in the industry. He initiated Chesapeake’s footing in Appalachia, which emerged as a renowned gas production center in the country. Aubrey’s leadership and passion for the oil and gas industry effected community in a great way. However, controversy still clung to him even after he left Chesapeake. Aubrey was accused of collaborating with a competitor to maintain low prices of the drilling rights.
Stepping down from Chesapeake did not shutter McClendon’s dreams. He founded his company where he was the C.E.O. His net worth after leaving Chesapeake was $35.6 billion. McClendon was known for working hard, and playing harder. He enjoyed the best things that money can buy. Aubrey spent lavishly by buying big homes, antique boats ad a wine cellar.
Besides the oil industry, Aubrey has invested in multiple businesses like restaurants, and real estate agencies in Oklahoma. He is also a philanthropist to private and public service.
Born : April 15, 1953 (age 63), Kalpakancheri
Spouse : Nazeera Azad
Net worth : 1.46 billion USD (2015) Forbes
Residence : Dubai, United Arab Emirates
Parents : Ahmed Unni Moopen
Education : Calicut Medical College
Azad Moopen (born 15 April 1953 in Kalpakancheri, Kerala) is an Indian physician and philanthropist, and a developer of healthcare facilities in Asia-Pacific. He is the chairman and managing director of Aster DM Healthcare, a healthcare conglomerates in the Middle East and India founded in 1987. In 2010 and 2011, he was awarded the Pravasi Bharatiya Samman and Padma Shri by the Government of India, respectively.According to Forbes, he is ranked 6th in the Top 100 Indian Leaders in UAE list, and according to Arabian Business, 29th in the 50 Richest Indians in the GCC, with the total wealth estimated to approximately $1.1 bln Forbes 2015).
Career:
In 1982, he started his career at the Calicut Medical College, where he served as a Medical Lecturer for five years before moving to Dubai in 1987. There he starting a single doctor practice at his own clinic. Over the last 26 years, he established a chain of healthcare facilities in West Asia with 175 unit hospitals, poly clinics, pharmacies and diagnostic centers in UAE, Qatar, Oman and Saudi Arabia. His firm, Aster DM Healthcare employs about 10,000 people in the Middle East, and serves more than 7 million patients a year.
Healthcare development in India:
Dr. Azad has been involved in the development of healthcare facilities in India. MIMS hospitals directly employ about 3,000 people.
He participated in establishing the 600-bed tertiary care Malabar Institute of Medical Sciences (MIMS) hospital at Kozhikode in Kerala in 2001. This was the first multi-specialty hospital in India to receive National Accreditation Board for Hospitals & Healthcare Providers accreditation in 2007. The second 150-bed MIMS hospital was set up at Kottakkal in Malappuram district in 2009.
MIMS Charitable Trust under his leadership established a rural health centre at the backward Vazhayur Panchayat near Kozhikode in 2008 and adopted 7,000 BPL members for comprehensive free out-patient and in-patient care. The trust is adopting the BPL population in the three wards around MIMS in the Corporation of Kozhikode and also plans to conduct a breast and cervical cancer screening program.
Awards and recognitions:
The following is the list of awards and recognitions received by Dr. Moopen:
Padma Shri Awards by the Government of India(2011)
Pravasi Bharatiya Samman by the Government of India (2010)
Arab Health Award for "Outstanding Contribution of an Individual to the Middle East Healthcare Industry" (2010)
Best Doctor Award by the Government of Kerala (2009)
Dubai Service Excellence Award (2004) by the Government of Dubai, United Arab Emirates for the Group
Kerala Ratna Award by Keraleeyam presented by Shri K G Balakrishnan, Hon. Chief Justice of India, in New Delhi (2008)
Aslam Kshema Award by Kshema Foundation for outstanding effort to help economically deprived people (2009)
Azim Premji is the chairman of Wipro Limited, an Indian software company that is among the leaders in the industry. He also has his own private equity fund called PremjiInvest that is tasked with managing his billion dollar personal portfolio. He also donates a tidy sum to help improve health care and education.
He is the king of the oil-rich kingdom of Saudi Arabia. He was also the country’s Regent from 1996 to 2005. He also served as Commander of the National Guards from 1962 to 2010.
He is the nephew of the King of Saudi Arabia. He is known as the “Warren Buffett of Saudi Arabia” because of his investment savvy. He is an avid collector of exotic cars, lavish palaces and expensive airplanes.
Abigail Pierrepont Johnson was born into the world in 19th December, 1961. He is an American very rich person finance manager. Since 2014, Johnson has been president and CEO of American venture firm Fidelity Investments (FMR), and director of its global sister organization Fidelity International (FIL). Loyalty was established by her granddad Edward C. Johnson II. Her dad Edward C. "Ned" Johnson III remaining parts administrator emeritus of FMR. As of March 2013, the Johnson family possessed a 49% stake in the organization, with Johnson herself holding an expected 24.5%.
In November 2016, Johnson was named director and remained CEO and president, giving her full control of Fidelity with 45,000 representatives around the world. Johnson's abundance is roughly $22.6 billion, making her one of the world's most well off ladies. She was named by Forbes as The Richest Person In America's 50 Largest Cities in 2016 and positioned #9 as Powerful Women in 2020. She was additionally the most extravagant individual in Massachusetts in 2020.
Johnson went to Cambridge, MA non-public school Buckingham Browne and Nichols prior to moving on from Hobart and William Smith school with a four year education in liberal arts degree in craftsmanship history in 1984. Subsequent to functioning as a specialist at Booz Allen Hamilton, where she met her better half, Johnson finished a MBA at Harvard Business School.
After moving on from Harvard Business School in 1988, Johnson joined Fidelity Investments, which her granddad Edward Johnson II established in 1946 – as an examiner and portfolio director. In 2001, she was elevated to President of Fidelity Asset Management. In 2005, she became Head of Retail, Workplace, and Institutional Business. She was named president in 2012. In 2014, she became CEO, a job her dad had held since 1977, and in 2016 she became administrator too. In 2018, Johnson presented digital currency venture at Fidelity, making it workable for institutional financial backers to exchange bitcoin and ethereum. In 2015, Johnson gave $2,700, the most extreme sum lawfully took into consideration official essential missions, to Republican official up-and-comer Jeb Bush. Johnson has filled in as an individual from the Committee on Capital Markets Regulation and as an individual from the directorate of the Securities Industry and Financial Markets Association (SIFMA) and of MIT. She is the solitary lady to serve on the leading group of the Financial Services Forum.
Adar Poonawalla was born into the world in fourteenth January 1981. Adar Poonawalla was taught at The Bishop's School (Pune) and at the St Edmund's School Canterbury followed by the University of Westminster. He is the (CEO) of Serum Institute of India. Established in 1966 by his dad, Cyrus Poonawalla, it is the world's biggest immunization producer by number of portions delivered. In a meeting with 'The Times', Poonawalla proclaimed that he left India for London due to dangers requesting COVID-19 antibodies. Poonawalla likewise said that he will begin Covid immunization creation outside India notwithstanding the continuous creation in India. He was furnished with 'Y' class security by the Indian government before the dangers were unveiled.
Poonawalla joined the Serum Institute of India in 2001 subsequent to moving on from college. Then, at that point sending out its items to 35 nations, Poonawalla focused on the organization's global market, new items permit and getting pre-qualified by the World Health Organization for supply to United Nations Agencies including UNICEF and PAHO. Starting at 2015, he has helped the organization trade its items to more than 140 nations; 85 percent of its incomes are from abroad. In 2011, he turned into the CEO. In 2012, he assumed a significant part in the securing of Bilthoven Biologicals, a Netherlands-based government immunization fabricating organization. Poonawalla is a board individual from the GAVI Alliance, the worldwide antibody collusion. He started and dispatched in 2014; Serum Institute's oral polio immunization, which turned into a blockbuster for the organization. It was accounted for that he wanted to extend the item portfolio to incorporate antibodies for dengue, influenza and cervical disease during that very year. As of now he is the CEO of Serum Institute of India. On the 31st of May 2021, he was designated as the administrator of Magma Fincorp, a monetary administrations organization. In 2016, he was recorded by GQ Magazine and granted Philanthropist of the year. In 2017, he got Humanitarian Endeavor Award In Hall of Fame Awards 2017 and was additionally granted as Indian of the Year in CSR Business Category on CNN-News18 . In 2018, Chief Minister Devendra Fadnavis introduced the ET Edge Maharashtra Achievers Awards of Business Leader of the Year to Poonawala, he further got CNBC Asia's honor for Corporate Social Responsibility around the same time. In 2020, Adar was remembered for a Fortune magazine's '40 Under 40' posting in the medical care class. In March 2021, Adar has been declared Entrepreneur of the Year by Economic Times for unrivaled commitment in battling Covid-19 by effectively providing immense amounts of Covishield in India and internationally, an immunization created by Oxford-AstraZeneca and delivered in India by Serum Institute.
Albert Bourla was born into the world in 21st October, 1961 in Thessaloniki, Greece. He is a Greek veterinarian and the director and CEO of Pfizer, an American drug organization. He joined the organization in 1993 and has held a few chief parts across Pfizer's divisions. Preceding turning out to be CEO, Bourla filled in as head working official.
Notwithstanding the sheets of Pfizer and the Pfizer Foundation, he serves or has served on the sheets of the Biotechnology Innovation Organization, Catalyst, the Partnership for New York City, and the Pharmaceutical Research and Manufacturers of America. Bourla is additionally an individual from The Business Council and the Business Roundtable. He connects frequently with business and wellbeing pioneers like Bill Gates. Bourla was persuaded by an early love for creatures and medication and is attributed with reshaping Pfizer to be an organization centered around innovative work and marked patent-secured doctor prescribed medications. He is additionally credited with aiding the improvement of Improvac, which kills hog corrupt, and for pulling together Pfizer's antibody division to zero in on staphylococcus, clostridioides difficile contamination, baby illnesses, and the Pfizer–BioNTech COVID-19 immunization. He goes against government obstruction in drug estimating, which he accepts would hamper spending on improvement of new medications. His parents, who were Sephardi Jews, were among the 2,000 of 50,000 Jews in Thessaloniki to endure the Holocaust; his mom was minutes from execution by terminating crew when she was saved through a payoff paid to a Nazi Party official by her non-Jewish brother by marriage, while his dad turned out to be out of the Jewish ghetto when the occupants were taken to the Auschwitz inhumane imprisonment and crawled under a rock, never to see his folks again. Bourla and his better half live in Scarsdale, New York. He has two youngsters: a little girl and a son. He got $21 million in pay from Pfizer in 2020. Bourla is focused on his Greek legacy. He keeps a home in Chalkidiki, which he visits each summer. He is an ally of the Aris Thessaloniki sports club. To profit Greece, he coordinated antibody gifts, clinical guide for outcasts, and more than $1 million in medication to help uninsured patients. He set up the Pfizer Artificial Intelligence Center in his old neighborhood, coordinated Pfizer's support in the Thessaloniki International Fair, is dear companions with Geoffrey R. Pyatt, United States Ambassador to Greece, and he brought Pfizer's administration group to Greece to meet with Prime Minister of Greece Kyriakos Mitsotakis. His political commitments have generally been to Republicans either from the Northeastern United States or that go against controls on doctor prescribed medication costs in the United States. He is routinely highlighted by CNBC and The New York Times and makes week after week posts on LinkedIn advancing Pfizer's work.
Bourla joined Pfizer in 1993, first filling in as a specialist of veterinary medication and specialized chief for the organization's creature wellbeing division in Greece. In 2001, he emigrated to the United States. He held numerous leader jobs at Zoetis (then, at that point known as Animal Health) and different divisions of Pfizer. From 2005 to 2009, he filled in as region president for Animal Health's Europe, Africa and Middle East division during. In 2009 and 2010, he regulated the Europe, Africa, and Asia Pacific division. In the last job, he dealt with the consolidation of Wyeth's Fort Dodge Animal Health business with Pfizer in these regions. From 2010 to 2013, Bourla filled in as president and head supervisor of Pfizer's Established Products Business Unit. There, he constructed business for the organization's medications that had as of late lost patent exclusivity. From January 2014 to January 2016, Bourla filled in as Group President of Pfizer's Global Vaccines, Oncology, and Consumer Healthcare business, where he drove Pfizer's work on disease and heart drugs, among others, and aided dispatch Eliquis, an anticoagulant, and Ibrance, a bosom malignancy treatment drug. From February 2016 to December 2017, he was bunch leader of Pfizer Innovative Health. In 2016, during his residency, Innovative Health's income expanded by 11%. Bourla turned into Pfizer's head working official (COO) on January 1, 2018, managing the organization's medication advancement, assembling, deals, and strategy. He rebuilt Pfizer and turned off the purchaser medical services business during his residency as COO. He was elevated to CEO in October 2018, viable January 1, 2019, succeeding Ian Read, his guide. In 2020, he was positioned as America's top CEO in the drug business by Institutional Investor. Bourla is an individual from The Business Council, an association of business pioneers settled in Washington, D.C., and the Business Roundtable, a gathering of CEOs of major U.S. organizations set up to advance favorable to business public approach.